<DOC>
	<DOCNO>NCT01831960</DOCNO>
	<brief_summary>This study design determine hypothalamic-pituitary-adrenal ( HPA ) axis suppression potential pharmacokinetic ( PK ) property CB-03-01 Cream , 1 % , apply every twelve hour two week , subject acne vulgaris age 12 year old .</brief_summary>
	<brief_title>An Evaluation Adrenal Suppression Potential Pharmacokinetic Properties CB-03-01 Cream Subjects With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Subject moderate severe facial acne vulgaris determine Investigator 's Global Assessment ( IGA ) obvious acne chest and/or back study start . Subject facial acne vulgaris ( include nose ) minimum number inflammatory lesion ( papule , pustule , nodules/cysts ) minimum number noninflammatory lesion ( open close comedo ) study start . Females must postmenopausal , surgically sterile use highly effective birth control method negative urine pregnancy test ( UPT ) study start . Subject must general good health opinion investigator , normal renal function , base screen physical examination , medical history , clinical laboratory value . Subject pregnant , lactating , plan become pregnant study . Subject 1220 year age Body Mass Index ( BMI ) age percentile &gt; 85 % . Subject &gt; 20 year age BMI &gt; 32.0 kg/m2 . Subject use tobacco , smoke cessation product , product contain nicotine within three month prior study start . Except use contraceptive , subject use prescription drug herbal product within 14 day prior dose , nonprescription drug vitamin mineral supplement within 7 day prior study start ; know enzymeinducer , enzymeinhibitor , report chronic exposure enzymeinducers paint solvent pesticide within 30 day study start . Subject use topical antiacne medication contain retinoids tazarotene , adapalene tretinoin , within four week study start . Subject use follow systemic antiacne medication : antibiotic within two week study start , spironolactone within four week study start , retinoid therapy within three month study start . Subject skin medical condition , include facial hair could interfere evaluation test article require use interfere topical systemic therapy . Subject need plan expose artificial tanning device excessive sunlight study . Subject use light treatment , microdermabrasion chemical peel face , chest back within eight week study start . Subject avoid type strenuous exercise ( swimming , run , team sport , etc. , ) use hot tubs/saunas study start end study . Subject receive investigational drug treat investigational device within 30 day prior study start . Subject currently enrol investigational drug device study . Subject use topical corticosteroid ( include inhale intranasal corticosteroid ) within two week study start . Subject use systemic corticosteroid ( include intramuscular intralesional injection ) within four week study start . Subject irregular sleep schedule work night shift . Subject experience significant blood loss within 60 day donate plasma within 72 hour prior study start . Subject test positive Screening human immunodeficiency virus ( HIV ) know seropositive HIV . Subject test positive Screening hepatitis B surface antigen , hepatitis C antibody history positive result . Subject major surgery within 30 day prior study start plan surgery study . Subject participate previous CB0301 study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Intrepid</keyword>
	<keyword>cortexolone</keyword>
	<keyword>cortexolone 17Î±-propionate</keyword>
	<keyword>anti-androgen</keyword>
</DOC>